Searching... Searching...
  • NVP -5.51%
  • Köp 2.99
  • Sälj 3.00
  • Senast 3.00
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

Our Projects

Our Projects

We develop treatments for mitochondrial diseases that lack adequate treatment

Read More

Our Strategy

Our Strategy

Our goal at NeuroVive is to translate mitochondrial science to clinical practice

Read More

Our People

Our People

The team at NeuroVive is driven by the passion to make health care better

Read More

Our Partners

Our Partners

NeuroVive works with international organizations in academia and industry

Read More

NeuroVive's focus is on developing drug candidates that maintain mitochondrial integrity and improves their function.

  • Press Releases

    NeuroVive receives Vinnova funding to support development of NV354, a novel treatment for genetic mitochondrial disorders 15 November Lund, 15 November, 2018- NeuroVive Pharmaceutical AB(Nas... Read More

Focus areas

NeuroVive's focus is on developing drug candidates that maintain mitochondrial integrity and improves their function.

Read More